Literature DB >> 31321582

Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study.

Xiu-Ping Zhang1, Teng-Fei Zhou2, Zhi-Heng Wang3, Fan Zhang4, Cheng-Qian Zhong5, Yi-Ren Hu6, Kang Wang1, Zong-Tao Chai1, Zhen-Hua Chen1, Meng-Chao Wu1, Wan Yee Lau1,7, Shu-Qun Cheng8.   

Abstract

BACKGROUND: Microvascular invasion (MVI) predicts poor prognosis in patients with hepatocellular carcinoma (HCC). HCC patients with hypercoagulability are prone to develop thrombosis; however, the relationship between preoperative coagulability state, as reflected by the international normalized ratio (INR) level, and MVI remains unclear.
METHODS: From January 2009 to December 2012, HCC patients who underwent R0 liver resection (LR) from four cancer centers entered into this study. The overall survival (OS) and recurrence-free survival (RFS) rates were compared using the Kaplan-Meier method and Cox regression analysis.
RESULTS: Of the 2509 HCC patients who were included into this study, 1104 were found to have MVI in the resected specimens. These patients were divided into the low (n = 151), normal (n = 796), and high (n = 157) INR subgroups based on the preoperative INR levels. The low INR subgroup had a significantly higher incidence of MVI than the normal or high INR subgroups (61.6% vs. 41.6% vs. 44.6%; p < 0.001). HCC patients with MVI were significantly more likely to have a low preoperative INR level (p < 0.001); the INR level (p < 0.001) was an independent risk factor of OS and RFS. HCC patients with MVI in the low INR subgroup had significantly worse RFS and OS than the normal or high INR subgroups (median RFS 13.5 vs. 20.2 vs. 21.6 months, p < 0.001; median OS 35.5 vs. 59.5 vs. 57.0 months, p < 0.001).
CONCLUSIONS: Preoperative hypercoagulability was associated with poor long-term prognosis in HCC patients with MVI after R0 LR.

Entities:  

Mesh:

Year:  2019        PMID: 31321582     DOI: 10.1245/s10434-019-07504-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.

Authors:  Shuangchi Liu; Zhiduan Xu; Zhuling Fang; Dengyong Zhang; Zhongqiang Qin; Longfei Fan; Jiakang Duan; Hongxiang Yin; Yigang Zhang; Qing Pang; Yi Tan
Journal:  Int J Gen Med       Date:  2021-08-10

2.  Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma.

Authors:  Xiao-Lu Ma; Wei-Guo Tang; Min-Jie Yang; Su-Hong Xie; Min-Le Wu; Guo Lin; Ren-Quan Lu
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

3.  A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics.

Authors:  Jin Wang; Zhi-Wen Ding; Kuang Chen; Yan-Zhe Liu; Nan Li; Ming-Gen Hu
Journal:  BMC Cancer       Date:  2021-12-16       Impact factor: 4.430

4.  Radiomics for the Preoperative Evaluation of Microvascular Invasion in Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Liujun Li; Chaoqun Wu; Yongquan Huang; Jiaxin Chen; Dalin Ye; Zhongzhen Su
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

5.  Preoperative aspartate aminotransferase to albumin ratio correlates with tumor characteristics and predicts outcome of hepatocellular carcinoma patients after curative hepatectomy: a multicenter study.

Authors:  Wei Peng; Junyi Shen; Junlong Dai; Shusheng Leng; Fei Xie; Yu Zhang; Shun Ran; Xin Sun; Tianfu Wen
Journal:  BMC Surg       Date:  2022-08-09       Impact factor: 2.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.